	MMP-2 rs243865 Polymorphism as a Risk Modifier of Hepatocellular Carcinoma in Taiwanese Males, Smokers and Alcohol Consumers. Anticancer Res Yueh TC, Wu MH, Yang MD, Lu MC, Shao YC, Ke TW, Wang ZH, Chen CA, Tsai CW, Bau DT, Chang WS. PMID: 42674711 [PubMed - indexed for MEDLINE]
	Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Res Kuwano A, Yada M, Tanaka K, Hamamoto T, Tanaka R, Kurosaka K, Suzuki H, Motomura K. PMID: 42674706 [PubMed - indexed for MEDLINE]
	Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma. Anticancer Res Takagi K, Nishiyama T, Kimura J, Fuji T, Yasui K, Fujiwara T. PMID: 42674693 [PubMed - indexed for MEDLINE]
	Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Anticancer Res Omori M, Komatsu S, Tada T, Ishihara N, Matsuura T, Ueshima E, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Sofue K, Kodama Y, Fukumoto T. PMID: 42674689 [PubMed - indexed for MEDLINE]
	Repeat Hepatectomy Versus Thermal Ablation for Intrahepatic Recurrence After Resection of Colorectal Liver Metastases: A Propensity-adjusted Analysis With Multiple Imputation. Anticancer Res Ikuta S, Aihara T, Nakajima T, Iwasaki T, Yamanaka N. PMID: 42674686 [PubMed - indexed for MEDLINE]
	Lesion-level Quantitative Post-therapy SPECT/CT During (177)Lu-DOTATATE PRRT for NET Liver Metastases. Anticancer Res Konishi K, Wakabayashi K, Ikenohira T, Yamashita R, Aramaki S, Ito S, Nakamura K. PMID: 42674685 [PubMed - indexed for MEDLINE]
	A Case of Concurrent Liver Metastases from Colorectal and Breast Cancer Diagnosed Using Percutaneous Tumor Biopsy. Anticancer Res Yusa T, Masuda T, Tomiguchi M, Nagayama Y, Miyamoto H, Komohara Y, Takematsu T, Adachi Y, Oda E, Ishiko T, Beppu T. PMID: 42674684 [PubMed - indexed for MEDLINE]
	Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study. J Vis Exp Hu QQ, Song ZJ, Shen NT, Jin W, Wu ML, Wu SW. PMID: 42667221 [PubMed - indexed for MEDLINE]
	FOXO6 as a Transcriptional Regulator of Hepatic Metabolic Inflammation and Hepatocarcinogenesis. IUBMB Life Kim ME, Kim Y, Lee JS. PMID: 42665991 [PubMed - indexed for MEDLINE]
	Early lenvatinib dose intensity is associated with survival in super-older adults (â‰¥80 years) with hepatocellular carcinoma: a real-world comparison with atezolizumab-bevacizumab. Eur J Gastroenterol Hepatol Kimura M, Nishikawa K, Imamura J, Kimura K. PMID: 42664455 [PubMed - indexed for MEDLINE]
	Dysregulation of circ-SMARCA5, circ-RHOT1, and HNF1A and the association of HNF1A polymorphisms with hepatocellular carcinoma. Mol Biol Rep Ibrahim BA, Elsayed BS, Gendia MA, Moustafa M, El Desoky AMZ. PMID: 42663735 [PubMed - indexed for MEDLINE]
	Proof-of-Concept Study of Hyperpolarized [1-(13)C]Pyruvate MRI in Participants with Hepatocellular Carcinoma. Radiol Imaging Cancer Kjærgaard U, Bøgh N, Aastrup M, Kristensen MH, Christensen NV, Sivesgaard K, Ringgaard S, Bonde Bertelsen L, Hansen ESS, Grønbæk H, Villadsen GE, Laustsen C. PMID: 42663532 [PubMed - indexed for MEDLINE]
	Diagnostic Yield and Cost of Morphology-Guided Immunohistochemistry in Liver Tumors. Asian Pac J Cancer Prev Charoenlap C, Arunsawat P, Prateepchaiboon T, Chienwichai K, Chang A. PMID: 42663230 [PubMed - indexed for MEDLINE]
	Diagnostic and Prognostic Values of Microfibrillar-Associated Protein 5 and Heat Shock Protein 90 Alpha in Patients with HCV-Induced Hepatocellular Carcinoma Undergoing Locoregional Therapy. Asian Pac J Cancer Prev Mosbbah RAE, Abd El-Maksoud M, Abo El-Khair SM, Shiha U, El-Eraky A, Shabana W. PMID: 42663215 [PubMed - indexed for MEDLINE]
	Dysregulated Interleukin Expression in Iraqi Hepatocellular Carcinoma: Diagnostic and Prognostic Implications. Asian Pac J Cancer Prev Essa AM, Esaa SM, Hoidy WH, Al-Saadi MH. PMID: 42663209 [PubMed - indexed for MEDLINE]
	Development and Internal Validation of the SPR-HCC Score System: A Prognostic Tool for Survival Prediction in Hepatocellular Carcinoma in a Resource-Limited Setting. Asian Pac J Cancer Prev Neesanun S, Patumanond J. PMID: 42663200 [PubMed - indexed for MEDLINE]
	Impact of PD-1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib-Based Triple Therapy. Liver Int He J, Chen J, Yu B, Wei F, Liu W, Huang P, Wu S, You X, Chen Z, Lin Z, Guo W, Zhuang S, Chen Y, Chen Z. PMID: 42661423 [PubMed - indexed for MEDLINE]
	Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma. Clin Exp Med Lu S, Ma J, Wang X, Zhang L, Lu J, Hu J. PMID: 42661129 [PubMed - indexed for MEDLINE]
	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO Open Tan CK, Vogel A, Wong YF, Ho GF, Zhou J, Atmakusuma TD, Kulkarni P, Kodama T, Chon HJ, Bello M, Yong WP, Hsu C, Korphaisarn K, Tanasanvimon S, Chen SC, Lee SY, Sebastian MR, Huh SJ, Morizane C, Tiwari P, Kalista KF, Qin S, Smyth EC, Lim E, Hou TC, Pentheroudakis G, Shan CW, André F, Muthukkumaran T, Ducreux M. PMID: 42660571 [PubMed - indexed for MEDLINE]
	MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and Opportunities. Radiographics Tan CH, Jiang H, Wang YC, Low HM, Welle C, Zhou S, Brancatelli G, Venkatesh SK, Lee JM. PMID: 42658729 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77311

Page 1 of 3866



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy